Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.80 (+1.14%) Hang Seng
18,079.61 -150.59 (-0.83%) FTSE 100
8,282.04 +50.99 (+0.62%) Bitcoin USD
68,755.88 +669.20 (+0.98%) CMC Crypto 200
1,442.76 +14.19 (+0.99%)
Pieris Pharmaceuticals, Inc. (PIRS)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 9.70 |
| Open | 9.65 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 9.65 - 9.88 |
| 52-week range | 9.31 - 80.80 |
| Volume | |
| Avg. volume | 14,900 |
| Market cap | 12.922M |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -11.40 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Investors Don't See Light At End Of Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Tunnel And Push Stock Down 27%
To the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. ( NASDAQ:PIRS ) shares are down a considerable 27...
ZacksPieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's Why
Pieris Pharmaceuticals (PIRS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksPieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's What You Should Know
Pieris Pharmaceuticals (PIRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
© 2024 Yahoo. All rights reserved.